IGF Oncology, LLC

États‑Unis d’Amérique

Commandez votre montre hebdomadaire IGF Oncology, LLC
Quantité totale PI 15
Rang # Quantité totale PI 103 338
Note d'activité PI 0,9/5.0    2
Rang # Activité PI 477 515

Brevets

Marques

9 0
3 0
3 0
0
 
Dernier brevet 2022 - Insulin-like growth factor-chemo...
Premier brevet 2004 - Conjugates or co-administration ...

Derniers inventions, produits et services

2022 Invention Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome. Pr...
2019 Invention Fusion proteins containing insulin-like growth factor-1 and epidermal growth factor and variants ...
2018 Invention Insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome. Pro...
Invention An insulin-like growth factor-chemotherapeputic conjugate for treating myelodysplastic syndrome. ...
2011 Invention Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer. The invention...
2010 Invention Compounds and methods for treating cancer. The present invention provides a method of treating ca...
Invention Anti-cancer protein-platinum conjugates. The invention provides polypeptide-platinum conjugates ...
Invention Anti-cancer protein-platinum conjugates. The invention provides polypeptide-platinum conjugates c...
Invention Anti-cancer protein-platinum conjugates.

The invention provides polypeptide-plati...
2006 Invention Methods for enhancing radiation therapy. Methods of treating cancer are provided. The methods ar...
2005 Invention Toxins and radionuclides coupled to igf-1 receptor ligands for treatment of cancer.
Th...
2004 Invention Compounds and method for treating cancer. The present invention provides a method of treating can...
Invention Conjugates or co-administration of igf-1 receptor ligands with anti-cancer chemotherapeutic agent...